Lei Yu
Second Affiliated Hospital of Zhejiang University(CN)
Publications by Year
Research Areas
CAR-T cell therapy research, Virus-based gene therapy research, Myasthenia Gravis and Thymoma, Viral Infectious Diseases and Gene Expression in Insects, Liver Disease and Transplantation
Most-Cited Works
- → Lipid nanoparticles produce chimeric antigen receptor T cells with interleukin-6 knockdown in vivo(2022)111 cited
- → Laparoscopic-assisted total cyst excision of choledochal cyst and Roux-en-Y hepatoenterostomy(2004)99 cited
- → Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?(2023)31 cited
- → Molecular and cellular pathways in colorectal cancer: apoptosis, autophagy and inflammation as key players(2022)30 cited
- → Overall survival benefits provided by lenalidomide maintenance after chimeric antigen receptor T cell therapy in patients with refractory/relapsed diffuse large B-cell lymphoma(2022)25 cited
- → Cytopenia after chimeric antigen receptor T cell immunotherapy in relapsed or refractory lymphoma(2022)23 cited
- → CD20-specific chimeric antigen receptor-expressing T cells as salvage therapy in rituximab-refractory/relapsed B-cell non-Hodgkin lymphoma(2022)23 cited
- → Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients(2023)20 cited
- → Investigation of the risk factors to predict cytokine release syndrome in relapsed or refractory B-cell acute lymphoblastic leukemia patients receiving IL-6 knocking down anti-CD19 chimeric antigen receptor T-cell therapy(2022)18 cited
- → Oxygen therapy alleviates hepatic steatosis by inhibiting hypoxia-inducible factor-2α(2020)18 cited